Previous Article in Journal
Characterization of Antiretroviral Therapy (ART) Adherence Phenotypes and Psychosocial Symptom Clusters Among Black/African American (AA) and Hispanic/Latine Adolescents and Young Adults (AYAs) with HIV in the Adherence Connection for Counseling, Education, and Support (ACCESS-II) Trial
Previous Article in Special Issue
Endemicity, Clinical Features, Risk Factors, and the Potential for Severe Infection in Leptospira wolffii-Associated Leptospirosis in North-Central Bangladesh
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
This is an early access version, the complete PDF, HTML, and XML versions will be available soon.
Article

Lung Involvement in Patients with Leptospirosis in Tropical Australia; Associations, Clinical Course and Implications for Management

1
Department of Medicine, Cairns Hospital, Cairns, QLD 4870, Australia
2
Leptospirosis Reference Laboratory, Coronial and Public Health Sciences, Coopers Plains, QLD 4108, Australia
3
School of Medicine and Dentistry, James Cook University, Cairns, QLD 4870, Australia
4
The Kirby Institute, University of New South Wales, Sydney, NSW 2052, Australia
*
Author to whom correspondence should be addressed.
Trop. Med. Infect. Dis. 2025, 10(12), 333; https://doi.org/10.3390/tropicalmed10120333 (registering DOI)
Submission received: 28 October 2025 / Revised: 19 November 2025 / Accepted: 24 November 2025 / Published: 26 November 2025
(This article belongs to the Special Issue Leptospirosis and One Health)

Abstract

Lung involvement in patients with leptospirosis is associated with a more complicated disease course. However, the demographic and clinical associations of lung involvement are incompletely defined, and its optimal management is uncertain. This retrospective study examined consecutive patients admitted to a referral hospital in tropical Australia, with laboratory-confirmed leptospirosis between January 2015, and June 2024. Lung involvement was defined as new lung parenchymal changes on chest imaging at any point during the patients’ hospitalisation. The demographics, clinical findings and clinical course of the patients with and without lung involvement were compared. The median (interquartile range (IQR)) age of the 109 patients was 39 (24–56) years; 93/109 (85%) were male. Lung involvement was present in 62/109 (57%), 55 (89%) of whom had no documented comorbidities. Patients with lung involvement received antibiotics later in their disease course than those without lung involvement (after a median (IQR) of 5 (4–6) versus 3 (2–5) days of symptoms, p = 0.001). Lung involvement was frequently associated with multi-organ failure: patients with lung involvement were more likely to require intensive care unit admission than patients without lung involvement (41/62 (66%) versus 15/47 (32%), p < 0.001). Overall, 30/109 (28%) satisfied criteria for acute respiratory distress syndrome (ARDS) and 26/109 (24%) developed pulmonary haemorrhage. Patients with lung involvement received cautious fluid resuscitation, vasopressor support and prompt initiation of additional supportive care—including mechanical ventilation, renal replacement therapy and extracorporeal membranous oxygenation—guided by the patients’ physiological parameters and clinical trajectory. All 109 patients in the cohort were alive 90 days after discharge. Life-threatening lung involvement was identified in the majority of individuals in this cohort and occurred in young and otherwise well individuals. However, in Australia’s well-resourced health system excellent outcomes can be achieved using a standard contemporary approach to the management of a patient with undifferentiated infection while a confirmed diagnosis of leptospirosis is awaited.
Keywords: leptospirosis; lung disease; pulmonary haemorrhage; clinical management; critical care; tropical medicine; pathophysiology leptospirosis; lung disease; pulmonary haemorrhage; clinical management; critical care; tropical medicine; pathophysiology

Share and Cite

MDPI and ACS Style

Sykes, A.; Smith, S.; Stratton, H.; Staples, M.; Rosengren, P.; Brischetto, A.; Vincent, S.; Hanson, J. Lung Involvement in Patients with Leptospirosis in Tropical Australia; Associations, Clinical Course and Implications for Management. Trop. Med. Infect. Dis. 2025, 10, 333. https://doi.org/10.3390/tropicalmed10120333

AMA Style

Sykes A, Smith S, Stratton H, Staples M, Rosengren P, Brischetto A, Vincent S, Hanson J. Lung Involvement in Patients with Leptospirosis in Tropical Australia; Associations, Clinical Course and Implications for Management. Tropical Medicine and Infectious Disease. 2025; 10(12):333. https://doi.org/10.3390/tropicalmed10120333

Chicago/Turabian Style

Sykes, Adam, Simon Smith, Hayley Stratton, Megan Staples, Patrick Rosengren, Anna Brischetto, Stephen Vincent, and Josh Hanson. 2025. "Lung Involvement in Patients with Leptospirosis in Tropical Australia; Associations, Clinical Course and Implications for Management" Tropical Medicine and Infectious Disease 10, no. 12: 333. https://doi.org/10.3390/tropicalmed10120333

APA Style

Sykes, A., Smith, S., Stratton, H., Staples, M., Rosengren, P., Brischetto, A., Vincent, S., & Hanson, J. (2025). Lung Involvement in Patients with Leptospirosis in Tropical Australia; Associations, Clinical Course and Implications for Management. Tropical Medicine and Infectious Disease, 10(12), 333. https://doi.org/10.3390/tropicalmed10120333

Article Metrics

Back to TopTop